Artiva Biotherapeutics, Inc.

ARTVCIK 0001817241 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0028

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 19, 2026no items parsed May 8, 2026no items parsed May 8, 2026no items parsed Mar 10, 2026no items parsed Feb 24, 2026no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Artiva Biotherapeutics, Inc.

Name	Roles	Filings
Ra Capital Nexus Fund, L.P.	Director	3
Shah Rajeev M.	Director10% Owner	3
Baker Daniel G.	Director	2
Gc Cell Corp	10% Owner	2
Gc Corp.	10% Owner	2

Showing 11-15 of 36

Per pagePrevPage 3 of 8Next

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Artiva Biotherapeutics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#	Insider	Trades	Win rate	Avg	Median	Best	Worst
1	Aslan Fred	4	50%	-3.2%	-7.6%	+25.8%	-23.3%

All filings

59 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
May 28, 2026	Gc Corp. 10% Owner	PPurchase	1,085,069	$11.52	$12,499,995
May 19, 2026	Miralles Gines Diego President & Head of R&D	AGrant	77,500	$0.00	$0
May 19, 2026	Aslan Fred Chief Executive Officer · Director	SSale	27,116	$9.0077	$244,253
May 19, 2026	Banerjee Subhashis Chief Medical Officer	SSale	7,037	$9.0076	$63,386
May 19, 2026	Bush Jennifer COO, CLO, Compliance Officer	SSale	8,790	$9.0078	$79,179

Showing 1-5 of 59

Per pagePage 1 of 12Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value